Tata India Pharma & Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8689 Cr | ₹1208 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 21% | 26.49% |
Expense Ratio | 1.81 | 2.14 |
Manager | Sailesh Raj Bhan | Meeta Shetty |
ISIN Code | INF204K01968 | INF277K016A9 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | -7.02% | -6.48% |
6 Month | -4.77% | -3.83% |
1 Year | 10.69% | 15.54% |
3 Year | 18.33% | 19.01% |
5 Year | 23.9% | 23.54% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | - | - |
1 Year | 9.7% | 14.12% |
3 Year | 26.11% | 28.17% |
5 Year | 21.8% | 22.79% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 18.19% | 7.82% |
3 Year | 20.5% | 17.79% |
5 Year | 20.36% | 14.55% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 14.36% | 14.23% |
Sharp | 0.78% | 0.74% |
Beta | 0.87% | 0.9% |
Alpha | 1.67% | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Sailesh Raj Bhan | Meeta Shetty |
Total AUM | ₹96086 Cr | ₹17847 Cr |
Fund Manage | 5 | 5 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 4.4 | 5.39 |
Large Cap | 45.96 | 40.33 |
Mid Cap | 27.12 | 30.82 |
Small Cap | 22.52 | 23.46 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 4.4 | 5.39 |
Pharmaceuticals & Biotechnology | 75.86 | 76.28 |
Healthcare Services | 17.38 | 14.31 |
Retailing | 2.36 | 0.66 |
Fertilizers & Agrochemicals | - | 0.83 |
Chemicals & Petrochemicals | - | 0.39 |
Insurance | - | 2.14 |
Top Comparisons
Mahindra Manulife Equity Savings Fund - Regular Plan - Growth
3Y Returns7.69%
UTI Conservative Hybrid Fund - Regular Plan - Growth Option
3Y Returns9.77%
Nippon India Nifty Smallcap 250 Index Fund - Regular Plan - Growth Option
3Y Returns15.65%
Motilal Oswal Nifty Next 50 Index Fund - Regular plan - Growth
3Y Returns13.3%
Invesco India Infrastructure Fund - Growth Option
3Y Returns21.98%
UTI Infrastructure Fund-Growth Option
3Y Returns17.98%
Mahindra Manulife ELSS Tax Saver Fund- Regular Plan - Growth
3Y Returns11.37%
Axis ELSS Tax Saver Fund - Regular Plan - Growth
3Y Returns8.52%